GH1 and epilepsy: Underlying conditions, beside SCD, were identified in seven patients (63.6%) in the positive group, being one case of overweight, one of epilepsy, one of epilepsy and insulin resistance, one of bipolar disease, one of short stature undergoing growth hormone treatment, one of asthma and pyelocaliceal dilation, and one of asthma and left ventricular dilation.